Åsa has been with Cytiva based in Uppsala, Sweden since 2003 and is a Downstream and analytics SME, with a broad and deep understanding of viral vector processing. Due to her long experience and from customer interactions she has gained insights into common challenges and pitfalls in the area of viral vectors and vaccines as well as general protein purification and analysis. She has also worked with proteomics and fluorescent-based protein analysis technologies.
Åsa holds a PhD in Medical Biochemistry from Uppsala University in 1999 based on research around biosynthesis of proteoglycans. The studies involved polysaccharide structure analysis, enzyme purification & cloning as well as characterizing an enzyme reaction
Also Speaking
Pete Robinson
Vice President, Medical and Scientific Management, Head, Cell and Gene Therapy Consortium • Syneos Health
24 November 2022
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania
16 December 2021
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023